This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...

Many biologically compelling proteins are deprioritized because they cannot be easily assayed in cells, creating a disconnect between biochemical discovery and physiological relevance. Debuted at the ...

This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for ...

Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition ...